Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.
about
ASARM peptides: PHEX-dependent and -independent regulation of serum phosphateExtracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemiaRegulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathwayA unified model for bone-renal mineral and energy metabolismNovel biological markers of bone: from bone metabolism to bone physiologyIncreased expression of matrix extracellular phosphoglycoprotein (MEPE) in cortical bone of the rat tibia after mechanical loading: identification by oligonucleotide microarrayMEPE is a novel regulator of growth plate cartilage mineralizationBmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells.PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolismAbnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.Surface immobilization of MEPE peptide onto HA/β-TCP ceramic particles enhances bone regeneration and remodeling.The bone-vascular axis in chronic kidney disease.A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemiaBone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.SPR4-peptide alters bone metabolism of normal and HYP mice.ASARM mineralization hypothesis: a bridge too far?Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'.Biomineralization of bone: a fresh view of the roles of non-collagenous proteins.Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motifThe chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.Do ASARM peptides play a role in nephrogenic systemic fibrosis?Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.In vivo impact of Dlx3 conditional inactivation in neural crest-derived craniofacial bonesInflammation and functional iron deficiency regulate fibroblast growth factor 23 production.Radiation activated CHK1/MEPE pathway may contribute to microgravity-induced bone density loss.Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.The osteocyte: an endocrine cell ... and more.Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice.MEPE Localization in the Craniofacial Complex and Function in Tooth Dentin Formation.An in situ hybridization study of perlecan, DMP1, and MEPE in developing condylar cartilage of the fetal mouse mandible and limb bud cartilage.MEPE's diverse effects on mineralization.Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy.The phosphate transporter NaPi-IIa determines the rapid renal adaptation to dietary phosphate intake in mouse irrespective of persistently high FGF23 levels.Bone Shaft Revascularization After Marrow Ablation Is Dramatically Accelerated in BSP-/- Mice, Along With Faster Hematopoietic Recolonization.Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.Acute Adaption to Oral or Intravenous Phosphate Requires Parathyroid Hormone.
P2860
Q24632241-4596910F-EB7B-4D59-90B6-277E9080D9FBQ27002346-308C6B65-DF66-42C1-BAF5-4103B8715CAAQ27026805-E5F00ECD-5FE8-4FCB-80E8-59641C050D50Q27690863-386361F6-DB94-46C7-8453-76AD8A5FA482Q28067712-2A437048-0239-41A8-8661-DCEF20F82D6AQ28534953-0DE05343-4614-45E1-A10B-847966881684Q28593877-FE554B0E-AB1D-4229-A3B1-0758FEA0E38FQ30544691-ED50501D-2A8B-497A-A105-E2ADB923CE13Q31161423-9781E132-8677-4833-A3CD-490B7297E4D3Q33617326-2410C481-70F3-4AE1-BF06-5511E0B35A14Q34249760-409CE066-9302-4B13-9A54-12CFD38F9893Q34402808-E83C3556-7999-4DF3-A1C5-933A5F3BEDC7Q34412241-250EFAB3-7BDB-46E6-8B28-85D2805374A9Q34602567-5795A581-E9E3-4290-B620-DB103646AB5FQ35105384-1C225969-5847-4381-BB87-895A8AE27CF7Q35128414-3046C2AD-0FFC-488C-93CC-25150174A8BEQ35156045-43D8F3E5-D77A-4121-AA21-BB50E6D9326BQ35218561-6B4201AE-9269-4B3F-956D-9933554C0DA0Q35606605-AACF1B97-B151-4C70-A357-89FFDAFC1D53Q35850452-AFCD8A85-004F-4121-A492-E9DE0C5AC250Q36074718-E5D9F3B4-EAC3-4431-996B-467F06BC99D4Q36237106-1C803FA8-879F-42E5-AB42-E3ECDA0E669CQ36367168-D27E7D93-992B-4157-940B-575FE49B2B27Q36446154-D0A934E0-EBAC-4397-BEE5-3B2D025D38A6Q36863458-ACA4C017-1EB2-4229-93F5-11F426B765FBQ36908748-3A453320-D27A-4F6D-AFEA-AAEAD5D78737Q37136264-DD89EBC3-6A5A-4DB5-863F-690121962EB6Q37203605-5B871F51-CE67-40BB-9B7A-12A8174DA144Q37607946-BB95085A-3675-45C2-B011-BEE19EF9D661Q39785963-D819BE27-4371-4580-8FB4-E51ABE4A9883Q41087451-D2C86D89-EABA-45B7-8857-18F791921500Q41763685-A4A77C5B-37DD-408F-93EF-FA27A9B7626DQ41788435-CE23518C-F8BE-4C55-B2FC-1B3397F1FD9AQ46185354-CB17E745-50F2-4843-95B6-9755273B03D3Q50959402-895DE51A-DF31-4AF4-86D8-A19F632F1E3EQ51430144-83D45BB1-020A-49ED-B60C-DED0ED1B0636Q54360634-AB78E15D-7591-4268-8019-ADC5F1E560ECQ55089216-D291046E-0070-40F7-9CFC-6EFA42FAA702
P2860
Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Matrix extracellular phosphogl ...... and vascularization modulator.
@ast
Matrix extracellular phosphogl ...... and vascularization modulator.
@en
type
label
Matrix extracellular phosphogl ...... and vascularization modulator.
@ast
Matrix extracellular phosphogl ...... and vascularization modulator.
@en
prefLabel
Matrix extracellular phosphogl ...... and vascularization modulator.
@ast
Matrix extracellular phosphogl ...... and vascularization modulator.
@en
P2093
P2860
P356
P1433
P1476
Matrix extracellular phosphogl ...... and vascularization modulator.
@en
P2093
Aline Martin
Anne-Marie Hedge
Peter S N Rowe
Valentin David
P2860
P304
P356
10.1210/EN.2009-0216
P407
P577
2009-06-11T00:00:00Z